Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanomaIRIE, Reiko F; OLLILA, David W; O'DAY, Steven et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 2, pp 110-117, issn 0340-7004, 8 p.Article

Redirected Lysis of Human Melanoma Cells by a MCSP/CD3-bispecific BiTE Antibody That Engages Patient-derived T CellsTORISU-ITAKURA, Hitoe; SCHOELLHAMMER, Hans F; SIM, Myung-Shin et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 8, pp 597-605, issn 1524-9557, 9 p.Article

Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanomaAZUMA, Yumiko; ISHIKAWA, Yuji; TSUCHIYA, Masayuki et al.Clinical cancer research. 2007, Vol 13, Num 9, pp 2745-2750, issn 1078-0432, 6 p.Article